Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT03043937 Completed - Clinical trials for Heart Disease Structural Disorder Abscess of Cardiac Septum

Cardiac Diseases With Pregnancy in Benisuef Localities

Start date: January 2015
Phase: N/A
Study type: Observational [Patient Registry]

The aim of this work is to demonstrate the variation of cardiac diseases among pregnant ladies in our localities, detect maternal & fetal complications and to predict the risk factors for poor maternal, fetal & neonatal outcomes

NCT ID: NCT03043742 Completed - Clinical trials for Chronic Ischemic Heart Disease

Stem Cell Heart Injections During Laser Revascularization Surgery for Treatment of Chronic Ischemic Heart Disease

Start date: July 12, 2016
Phase: Phase 1
Study type: Interventional

Assess the safety and effectiveness of stem cell application with regard to improvement in regional myocardial function in patients receiving Trans-Myocardial Laser Revascularization (TMR) and stem cells.

NCT ID: NCT03042104 Active, not recruiting - Heart Diseases Clinical Trials

EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis

EARLY TAVR
Start date: July 12, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the safety and effectiveness of the Edwards SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve (THV) compared with clinical surveillance (CS) in asymptomatic patients with severe, calcific aortic stenosis.

NCT ID: NCT03040947 Recruiting - Hypertension Clinical Trials

MRI Sequence and Imaging Protocol Development

BikeMRI
Start date: March 2016
Phase:
Study type: Observational

The purpose of this study is to develop imaging protocols when using cardiovascular magnetic resonance (CMR) to assess cardiac functions, morphology and tissue characterization. The National Heart Research Institute Singapore (NHRIS) houses two dedicated CMR scanners to support the numerous investigator initiated projects in patients with various cardiac pathologists. By optimizing novel CMR sequences used in these studies, scanning time can be shortened for patients with underlying cardiac diseases.

NCT ID: NCT03030495 Active, not recruiting - Clinical trials for Ischemic Heart Disease

Registry of Comprehensive Imaging and Physiological Evaluation of Deferred Lesions Based on FFR

IMPACT-FFR
Start date: December 2016
Phase:
Study type: Observational [Patient Registry]

1. To compare the risk of atherosclerotic lesion progression and subsequent patient-oriented composite outcomes (all-cause mortality, any MI, or any Ischemia-driven repeat revascularization) between deferred lesions with or without over microvascular disease, defined as physiological classification 2. To explore independent predictors of atherosclerotic lesion progression in deferred lesions based on fractional flow reserve-guided strategy and treated by contemporary medical treatment

NCT ID: NCT03029117 Completed - Clinical trials for Rheumatic; Heart Disease, Maternal, Affecting Fetus

Effect of Rheumatic Heart Disease on Maternal and Fetal Outcomes

Start date: February 1, 2016
Phase: N/A
Study type: Observational [Patient Registry]

It's prospective Cohort study to compare maternal and fetal outcomes in pregnant females between corrected and uncorrected rheumatic valve lesions

NCT ID: NCT03023644 Completed - Children Clinical Trials

Improving Neurodevelopmental Outcomes in Children With Congenital Heart Disease: An Intervention Study

Start date: February 21, 2017
Phase: N/A
Study type: Interventional

Each year, approximately 1 child in every 100 is born with Congenital Heart Disease (CHD), making it the most common birth defect. With recent medical advances, more children with CHD survive early open-heart surgery, so that there are now 2 to 3 million adult survivors with CHD. These survivors face challenges in terms of their cognitive and behavioral development. For many, the limitations affect their academic achievement, social adaption and, ultimately, their quality of life. Among the most disabling limitations are those that pertain to the ability to maintain attention, plan and organize activities, regulate emotions, and develop problem-solving strategies. Collectively, these are referred to as executive functions (EF) because they are higher-order abilities that enable one to coordinate complex behaviors. Additionally, impaired EF also underlie mental health disorders. In spite of the abundance of evidence that children with CHD struggle with EF, there is little to offer them in the way of evidence-based interventions to prevent or mitigate these problems. The investigators propose to conduct the first randomized trial to evaluate the efficacy of an intervention, the Cogmed Working Memory Program, in improving the neurodevelopment outcomes of children with critical CHD after infant open-heart surgery. Children who meet eligibility criteria and who agree to participate will be randomly assigned to an intervention or control group. Children in the intervention group will complete 25 35-40 minute sessions of Cogmed training, spread over for 5 weeks. This Program is a set of home-based, child-friendly, computerized activities. The control group will receive the standard of care for children with CHD. Children's scores on EF and related neurodevelopmental tests will be evaluated before the intervention group completes Cogmed training, at the conclusion of their training, and 3 months later. The latter assessment will indicate whether any gains in EF skills of the children in the intervention group are sustained after training. Parents and teachers will also complete questionnaires about children's EF, attention, and social behaviors to determine whether training affects behaviors of the intervention group at home and in school. The investigators will also identify the medical and surgical characteristics of children who benefit most from Cogmed training. This information will be helpful in targeting the intervention most efficiently in the future.

NCT ID: NCT03022669 Recruiting - Clinical trials for Coronary Heart Disease

Mobile Health Strategies for Veterans

Start date: December 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether text messages/messaging (TM) or a mobile application (app), compared with an educational website-control provided to all Veterans, can improve adherence to antiplatelet therapy among patients following acute coronary syndrome or percutaneous coronary intervention (ACS/PCI).

NCT ID: NCT03018717 Active, not recruiting - Clinical trials for Chronic Lung Disease

Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases

ATLAN_TIC01
Start date: June 13, 2016
Phase: N/A
Study type: Interventional

Information and communications technologies (ICT) currently constitute a key element in the innovation and improvement of providing health-care to frail populations with advanced chronic diseases, but it´s efficacy, safety and cost-effectiveness has not yet been proven conclusively. The investigators are going to carry out a multi-center, randomized, parallel groups, phase III clinical trial in adult patient with heart and/or lung advanced diseases,aiming to analyze the efficacy and cost-efficacy of tele-monitorization of bio-parameters added to optimal standard of clinical care (shared clinical care plan) compared to the shared clinical care plan exclusively.

NCT ID: NCT03016429 Completed - Cardiac Disease Clinical Trials

Safety and Clinical Outcomes of Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices

BIDMC-MRI
Start date: December 2016
Phase:
Study type: Observational

This protocol outlines a prospective study evaluating safety and clinical outcomes of magnetic resonance imaging (MRI) examinations performed on patients with cardiac implantable electrical devices (CIEDs) including pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs). This prospective study aims to improve the evidence base regarding this common clinical scenario. Specifically, the investigators aim to address whether results of MRI in PM/ICD patients affect physician decision making related to clinical management strategy and planning treatment interventions. Further, this study will evaluate whether the results of MRI in these patients affects patient outcomes related to survival and adverse events during or after MRI scanning.